| scholarly article | Q13442814 |
| P50 | author | Bruce N Cronstein | Q50056922 |
| Michael Pillinger | Q50129009 | ||
| C Montesinos | Q70475973 | ||
| Allison B. Reiss | Q38323575 | ||
| P2093 | author name string | Michael A Schwarzschild | |
| Herman Yee | |||
| Scott L Friedman | |||
| Jiang-Fan Chen | |||
| Patricia Fernandez | |||
| Edwin S L Chan | |||
| Avani Desai | |||
| David L Delano | |||
| P2860 | cites work | Molecular action of methotrexate in inflammatory diseases | Q24534771 |
| Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage | Q28214799 | ||
| Receptors for purines and pyrimidines | Q28283941 | ||
| A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury | Q28510918 | ||
| A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice | Q28594915 | ||
| Histological grading and staging of chronic hepatitis | Q29619625 | ||
| Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis | Q29619627 | ||
| Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection | Q30307082 | ||
| Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. | Q45240162 | ||
| Risk factors for development of lethal sequelae after hepatitis B virus infection in humans | Q45795601 | ||
| Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States | Q46847687 | ||
| Adenosine partially prevents cirrhosis induced by carbon tetrachloride in rats | Q46972258 | ||
| Tuberculous peritonitis: a study comparing cirrhotic and noncirrhotic patients. | Q54734068 | ||
| A new physiological function for adenosine: regulation of superoxide anion production | Q57731184 | ||
| Role of Adenosine A1 and A2A Receptors in the Alcohol Withdrawal Syndrome | Q60440924 | ||
| Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver | Q68718624 | ||
| Possible role of cell redox state on collagen metabolism in carbon tetrachloride-induced cirrhosis as evidenced by adenosine administration to rats | Q72062105 | ||
| Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: evidence for A2 receptors on rat Kupffer cells | Q72431009 | ||
| Coffee, tea, and mortality | Q72691558 | ||
| Coffee, alcohol, and the liver | Q73029270 | ||
| Anti-arthritic effect of methotrexate: is it really mediated by adenosine? | Q73422815 | ||
| Adenosine deaminase isoenzymes and neopterin in liver cirrhosis | Q73579256 | ||
| Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression | Q77753654 | ||
| Absence of the adenosine A(2A) receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice | Q31882968 | ||
| Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy | Q33706858 | ||
| Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury | Q33822590 | ||
| The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. | Q33909650 | ||
| Mechanisms of alcoholic liver injury | Q33911617 | ||
| The role and regulation of adenosine in the central nervous system | Q34205330 | ||
| Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells | Q34538916 | ||
| Activation of hepatic stellate cells--a key issue in liver fibrosis | Q34565618 | ||
| Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. | Q35747902 | ||
| Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. | Q36349017 | ||
| Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors | Q36380776 | ||
| Modulation of human dermal fibroblast extracellular matrix metabolism by the lymphokine leukoregulin | Q36529940 | ||
| Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. | Q37208648 | ||
| Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells | Q37443977 | ||
| An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. | Q38311930 | ||
| Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. | Q38333252 | ||
| Turnover of adenosine in plasma of human and dog blood | Q39525884 | ||
| Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway | Q39793259 | ||
| Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides | Q39797150 | ||
| Determination of hydroxyproline | Q39967323 | ||
| Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells. | Q40628587 | ||
| Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. | Q40681279 | ||
| Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. | Q40779392 | ||
| Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate | Q40926286 | ||
| Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. | Q41361630 | ||
| Hepatic adenosine in rats fed ethanol: effect of acute hyperoxia or hypoxia | Q41375390 | ||
| Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. | Q41744358 | ||
| Hepatotoxicity of Long-Term Methotrexate Therapy for Psoriasis | Q42235362 | ||
| The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease | Q43038426 | ||
| A therapeutic strategy to prevent morphine dependence and tolerance by coadministration of cAMP-related reagents with morphine. | Q43070596 | ||
| The use of adenosine deaminase as a diagnostic tool for peritoneal tuberculosis | Q43683388 | ||
| Coffee, caffeine, and the risk of liver cirrhosis | Q43737586 | ||
| Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats | Q43755015 | ||
| Does coffee protect against liver cirrhosis? | Q43795142 | ||
| Regulation of glycogen metabolism in hepatocytes through adenosine receptors. Role of Ca2+ and cAMP. | Q43915720 | ||
| Effect of endotoxin pretreatment on hepatic stellate cell response to ethanol and acetaldehyde. | Q43923523 | ||
| Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel). | Q43950010 | ||
| Regulation of endothelin-A receptor sensitivity by cyclic adenosine monophosphate in rat hepatic stellate cells | Q44151762 | ||
| A3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure | Q44185781 | ||
| The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells | Q44215015 | ||
| Low ethanol sensitivity and increased ethanol consumption in mice lacking adenosine A2A receptors. | Q44228562 | ||
| Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade | Q44628396 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver cirrhosis | Q147778 |
| P304 | page(s) | 1144-1155 | |
| P577 | publication date | 2006-06-19 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis | |
| P478 | volume | 148 |
| Q38588143 | A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives |
| Q24652486 | A2A receptors in inflammation and injury: lessons learned from transgenic animals |
| Q43677765 | Absence of the adenosine A(2A) receptor attenuates hypertrophic scarring in mice |
| Q36312718 | Activated hepatic stellate cells upregulate transcription of ecto-5'-nucleotidase/CD73 via specific SP1 and SMAD promoter elements |
| Q37707427 | Activation of adenosine receptor A2A increases HSC proliferation and inhibits death and senescence by down-regulation of p53 and Rb. |
| Q42582009 | Adenine induces differentiation of rat hepatic stellate cells |
| Q34853017 | Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis |
| Q37503660 | Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2/3. |
| Q33783389 | Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice |
| Q33765783 | Adenosine A(2A) receptors promote collagen production by a Fli1- and CTGF-mediated mechanism. |
| Q47102657 | Adenosine A2A Receptor Deletion Blocks the Beneficial Effects of Lactobacillus reuteri in Regulatory T-Deficient Scurfy Mice |
| Q37468682 | Adenosine A2A receptor (A2AR) is a fine-tune regulator of the collagen1:collagen3 balance |
| Q82237362 | Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system |
| Q35190917 | Adenosine A2A receptor blockade or deletion diminishes fibrocyte accumulation in the skin in a murine model of scleroderma, bleomycin-induced fibrosis. |
| Q36385392 | Adenosine A2A receptor plays an important role in radiation-induced dermal injury |
| Q34686068 | Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development. |
| Q50197688 | Adenosine A2a Receptor Blockade Diminishes Wnt/β-Catenin Signaling in a Murine Model of Bleomycin-Induced Dermal Fibrosis. |
| Q48859170 | Adenosine Increases Hepatic Artery Flow in Liver Transplant Recipients: A Pilot Study |
| Q39004042 | Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases |
| Q35085245 | Adenosine in fibrosis. |
| Q35085307 | Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition |
| Q28295173 | Adenosine inhibits renin release from juxtaglomerular cells via an A1 receptor-TRPC-mediated pathway |
| Q30432457 | Adenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient mice |
| Q88788960 | Adenosine receptor distribution in Rhesus monkey ocular tissue |
| Q35263957 | Adenosine receptors and fibrosis: a translational review |
| Q29346491 | Adenosine receptors as drug targets--what are the challenges? |
| Q37565195 | Adenosine receptors in wound healing, fibrosis and angiogenesis. |
| Q41971814 | Adenosine signaling contributes to ethanol-induced fatty liver in mice. |
| Q34035228 | Adenosine signaling during acute and chronic disease states |
| Q92486062 | Adenosinergic Signaling in Liver Fibrosis |
| Q46341987 | An Elf2-like transcription factor acts as repressor of the mouse ecto-5'-nucleotidase gene expression in hepatic myofibroblasts |
| Q43153947 | Anti-metabolic syndrome effects of adenosine ingestion in stroke-prone spontaneously hypertensive rats fed a high-fat diet |
| Q35370819 | Antilipogenic and anti-inflammatory activities of Codonopsis lanceolata in mice hepatic tissues after chronic ethanol feeding |
| Q40092383 | Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. |
| Q28080872 | Beneficial and detrimental role of adenosine signaling in diseases and therapy |
| Q44147553 | Blocking adenosine A2A receptor reduces peritoneal fibrosis in two independent experimental models. |
| Q92707925 | CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A2B Adenosine Receptor Signaling |
| Q48140668 | Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats. |
| Q35135195 | Caffeine inhibits the activation of hepatic stellate cells induced by acetaldehyde via adenosine A2A receptor mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK signal pathway |
| Q33938555 | Caffeine, a drug for all seasons. |
| Q51125370 | Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats. |
| Q37776184 | Cell Death and Fibrogenesis |
| Q33569405 | Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis |
| Q85394166 | Chronic caffeine intake increases androgenic stimuli, epithelial cell proliferation and hyperplasia in rat ventral prostate |
| Q40068043 | Coffee Consumption and Risk of Biliary Tract Cancers and Liver Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies |
| Q30473375 | Current status of novel antifibrotic therapies in patients with chronic liver disease |
| Q37960072 | Design and application of locally delivered agonists of the adenosine A(2A) receptor |
| Q39572713 | Ecto-5'-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line |
| Q46246600 | Effect of unfiltered coffee on carbon tetrachloride-induced liver injury in rats |
| Q64107472 | Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats |
| Q37768335 | Evolving challenges in hepatic fibrosis |
| Q41675213 | Extracellular adenosine controls NKT-cell-dependent hepatitis induction |
| Q34135461 | Genetic deletion of the adenosine A2A receptor confers postnatal development of relative myopia in mice |
| Q34387063 | Hepatic stellate cells and liver fibrosis |
| Q29616840 | Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver |
| Q47829842 | Hepatoprotective Effect of Low Doses of Caffeine on CCl4-Induced Liver Damage in Rats. |
| Q42747703 | How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations |
| Q35528026 | Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor |
| Q26752304 | Hypoxia-inducible factors as molecular targets for liver diseases |
| Q35560040 | I drink for my liver, Doc: emerging evidence that coffee prevents cirrhosis. |
| Q33694628 | Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling |
| Q39623703 | Interferon-gamma inhibits adenosine A2A receptor function in hepatic stellate cells by STAT1-mediated repression of adenylyl cyclase |
| Q29619336 | Mechanisms of hepatic fibrogenesis |
| Q38581885 | Mechanistic review of drug-induced steatohepatitis |
| Q89559208 | Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis |
| Q89748484 | Methotrexate and its mechanisms of action in inflammatory arthritis |
| Q47725430 | Methotrexate modulates the expression of MMP-1 and type 1 collagen in dermal fibroblast |
| Q38945736 | Methotrexate promotes glucose uptake and lipid oxidation in skeletal muscle via AMPK activation |
| Q43144564 | Methotrexate--how does it really work? |
| Q37791059 | Methylxanthines, Inflammation, and Cancer: Fundamental Mechanisms |
| Q37628490 | Molecular Bases Underlying the Hepatoprotective Effects of Coffee. |
| Q55082101 | Monitoring methotrexate-induced liver fibrosis in patients with psoriasis: utility of transient elastography. |
| Q39523639 | New role of the human equilibrative nucleoside transporter 1 (hENT1) in epithelial-to-mesenchymal transition in renal tubular cells. |
| Q35079069 | Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine. |
| Q34979922 | Obesity, diabetes mellitus, and liver fibrosis |
| Q37326848 | Part I: Liver function in oncology: biochemistry and beyond |
| Q36691126 | Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine |
| Q37358974 | Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model |
| Q42367885 | Purinergic Signalling: Therapeutic Developments |
| Q34008598 | Purinergic receptors in gastrointestinal inflammation |
| Q90429521 | Purinergic signaling in hepatic disease |
| Q36385326 | Purinergic signaling in scarring |
| Q38165746 | Purinergic signalling in the liver in health and disease |
| Q36296620 | Recovery of the Cell Cycle Inhibition in CCl(4)-Induced Cirrhosis by the Adenosine Derivative IFC-305. |
| Q28742066 | Renal effects of the novel selective adenosine A1 receptor blocker SLV329 in experimental liver cirrhosis in rats |
| Q49680083 | Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study. |
| Q38268013 | SEURAT-1 liver gold reference compounds: a mechanism-based review |
| Q30440124 | Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction |
| Q38710133 | Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis |
| Q33639481 | Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis |
| Q35625864 | The Value of Circulating Nogo-B for Evaluating Hepatic Functional Reserve in Patients with Cirrhosis |
| Q30436868 | The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion |
| Q96230894 | The adenosine pathway in immuno-oncology |
| Q37524827 | The adenosinergic immunomodulatory drugs |
| Q46837128 | The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin. |
| Q46842154 | The cardioprotective effects of L-carnitine on rat cardiac injury, apoptosis, and oxidative stress caused by amethopterin |
| Q52733589 | The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis. |
| Q38233128 | The role of adenosine receptors A2A and A2B signaling in renal fibrosis |
| Q37677794 | Transcriptomic effects of adenosine 2A receptor deletion in healthy and endotoxemic murine myocardium |
| Q24644038 | Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions |
Search more.